Cytokinetics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytokinetics and other ETFs, options, and stocks.About CYTK
Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility.
CYTK Key Statistics
Stock Snapshot
With a market cap of 7.84B, Cytokinetics(CYTK) trades at $64.12. The stock has a price-to-earnings ratio of -10.16.
On 2025-12-09, Cytokinetics(CYTK) stock moved within a range of $63.52 to $66.37. With shares now at $64.12, the stock is trading +0.9% above its intraday low and -3.4% below the session's peak.
Trading volume for Cytokinetics(CYTK) stock has reached 1.5M, versus its average volume of 1.66M.
The stock's 52-week range extends from a low of $29.31 to a high of $69.33.
The stock's 52-week range extends from a low of $29.31 to a high of $69.33.
CYTK News
In recent days, Grabar Law Office began investigating Cytokinetics, Inc. for potential breaches of fiduciary duty related to allegedly misleading disclosures ab...
New insider activity at Cytokinetics ( (CYTK) ) has taken place on December 5, 2025. TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed i...